80_FR_82086 80 FR 81835 - National Cancer Institute; Amended Notice of Meeting

80 FR 81835 - National Cancer Institute; Amended Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 251 (December 31, 2015)

Page Range81835-81835
FR Document2015-32936

Federal Register, Volume 80 Issue 251 (Thursday, December 31, 2015) 
[Federal Register Volume 80, Number 251 (Thursday, December 31, 2015)]
[Notices]
[Page 81835]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-32936]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Special Emphasis Panel, February 2-3, 2016 08:00 a.m. 
to 05:00 p.m., Hilton Washington DC/Rockville, Rockville, MD 20852 
which was published in the Federal Register on December 7, 2015 80 FR 
76026.
    The meeting notice is amended to change the title from ``NCI P01 
Meeting II'' to ``NCI Program Project Meeting III''. The meeting is 
closed to the public.

    Dated: December 28, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-32936 Filed 12-30-15; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 251 / Thursday, December 31, 2015 / Notices 81835 Agenda: This portion of the meeting will the discussions could disclose Dea, Niddk, National Institutes of Health, be open to the public for announcements and confidential trade secrets or commercial Room 753, 6707 Democracy Boulevard, reports of administrative, legislative, and property such as patentable material, Bethesda, MD 20892–2542, (301) 594–8898, program developments in the drug abuse and personal information concerning barnardm@extra.niddk.nih.gov. field. Place: National Institutes of Health, individuals associated with the grant Name of Committee: National Institute of Neuroscience Center, 6001 Executive applications, the disclosure of which Diabetes and Digestive and Kidney Diseases Boulevard, Rockville, MD 20852. would constitute a clearly unwarranted Special Emphasis Panel—PAR–15–067: Contact Person: Susan R.B. Weiss, Ph.D., invasion of personal privacy. NIDDK Multi-Center Clinical Study (U01). Director, Division of Extramural Research, Name of Committee: National Institute of Date: February 8, 2016. Office of the Director, National Institute on Diabetes and Digestive and Kidney Diseases Time: 12:00 p.m. to 2:00 p.m. Drug Abuse, NIH, DHHS, 6001 Executive Special Emphasis Panel, T1D Risk Agenda: To review and evaluate grant Boulevard, NSC, Room 5274, MSC 9591, Assessment and Early Intervention applications. Rockville, MD 20892, 301–443–6487, Technologies (SBIR). Place: National Institutes of Health, Two sweiss@nida.nih.gov. Date: January 25, 2016. Democracy Plaza, 6707 Democracy Any member of the public interested in Time: 11:00 a.m. to 1:00 p.m. Boulevard, Bethesda, MD 20892 (Telephone presenting oral comments to the committee Agenda: To review and evaluate grant Conference Call). may notify the Contact Person listed on this applications. notice at least 10 days in advance of the Contact Person: Dianne Camp, Ph.D., Place: National Institutes of Health, Two meeting. Interested individuals and Democracy Plaza, 6707 Democracy Scientific Review Officer, Review Branch, representatives of organizations may submit Boulevard, Bethesda, MD 20892 (Telephone Dea, Niddk, National Institutes of Health, a letter of intent, a brief description of the Conference Call). Room 756, 6707 Democracy Boulevard, organization represented, and a short Contact Person: Thomas A. Tatham, Ph.D., Bethesda, Md 20892–2542, 301–5947682, description of the oral presentation. Only one Scientific Review Officer, Review Branch, campd@extra.niddk.nih.gov. representative of an organization may be Dea, Niddk, National Institutes of Health, (Catalogue of Federal Domestic Assistance allowed to present oral comments and if Room 760, 6707 Democracy Boulevard, Program Nos. 93.847, Diabetes, accepted by the committee, presentations Bethesda, MD 20892–5452, (301) 594–3993, may be limited to five minutes. Both printed tathamt@mail.nih.gov. Endocrinology and Metabolic Research; and electronic copies are requested for the 93.848, Digestive Diseases and Nutrition Name of Committee: National Institute of record. In addition, any interested person Diabetes and Digestive and Kidney Diseases Research; 93.849, Kidney Diseases, Urology may file written comments with the Special Emphasis Panel, Closed Loop and Hematology Research, National Institutes committee by forwarding their statement to Diabetes Technology (SBIR). of Health, HHS) the Contact Person listed on this notice. The Date: January 28, 2016. Dated: December 24, 2015. statement should include the name, address, Time: 2:00 p.m. to 5:00 p.m. telephone number and when applicable, the Agenda: To review and evaluate grant David Clary, business or professional affiliation of the applications. Program Analyst, Office of Federal Advisory interested person. Place: National Institutes of Health, Two Committee Policy. Information is also available on the Democracy Plaza, 6707 Democracy [FR Doc. 2015–32910 Filed 12–30–15; 8:45 am] Institute’s/Center’s home page: Boulevard, Bethesda, MD 20892 (Telephone Conference Call). BILLING CODE 4140–01–P www.drugabuse.gov/NACDA/ NACDAHome.html, where an agenda and Contact Person: Thomas A. Tatham, Ph.D., any additional information for the meeting Scientific Review Officer, Review Branch, will be posted when available. Dea, Niddk, National Institutes of Health, DEPARTMENT OF HEALTH AND Room 760, 6707 Democracy Boulevard, HUMAN SERVICES (Catalogue of Federal Domestic Assistance Bethesda, MD 20892–5452, (301) 594–3993, Program Nos.: 93.279, Drug Abuse and tathamt@mail.nih.gov. National Institutes of Health Addiction Research Programs, National Institutes of Health, HHS) Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases National Cancer Institute; Amended Dated: December 28, 2015. Special Emphasis Panel, NIDDK DEM Natasha M. Copeland, Fellowship Grant Review. Notice of Meeting Program Analyst, Office of Federal Advisory Date: January 31–February 2, 2016. Time: 6:00 p.m. to 5:00 p.m. Notice is hereby given of a change in Committee Policy. Agenda: To review and evaluate grant the meeting of the National Cancer [FR Doc. 2015–32938 Filed 12–30–15; 8:45 am] applications. Institute Special Emphasis Panel, BILLING CODE 4140–01–P Place: Melrose Hotel, 2430 Pennsylvania February 2–3, 2016 08:00 a.m. to 05:00 Ave. NW., Washington, DC 20037. p.m., Hilton Washington DC/Rockville, Contact Person: Carol J. Goter-Robinson, DEPARTMENT OF HEALTH AND Ph.D., Scientific Review Officer, Review Rockville, MD 20852 which was HUMAN SERVICES Branch, Dea, Niddk, National Institutes of published in the Federal Register on Health, Room 748, 6707 Democracy December 7, 2015 80 FR 76026. National Institutes of Health Boulevard, Bethesda, MD 20892–5452, (301) The meeting notice is amended to 594–7791, goterrobinsonc@ extra.niddk.nih.gov. change the title from ‘‘NCI P01 Meeting National Institute of Diabetes and II’’ to ‘‘NCI Program Project Meeting III’’. Digestive and Kidney Diseases; Notice Name of Committee: National Institute of of Closed Meetings Diabetes and Digestive and Kidney Diseases The meeting is closed to the public. Special Emphasis Panel, NEW NIDDK PARs Dated: December 28, 2015. Pursuant to section 10(d) of the on Pragmatic Research and Natural Melanie J. Gray, Federal Advisory Committee Act, as Experiments. Program Analyst, Office of Federal Advisory tkelley on DSK3SPTVN1PROD with NOTICES amended (5 U.S.C. App.), notice is Date: February 8, 2016. Time: 8:00 a.m. to 5:00 p.m. Committee Policy. hereby given of the following meetings. Agenda: To review and evaluate grant [FR Doc. 2015–32936 Filed 12–30–15; 8:45 am] The meetings will be closed to the applications. public in accordance with the Place: Bethesda Marriott Suites, 6711 BILLING CODE 4140–01–P provisions set forth in sections Democracy Boulevard, Bethesda, MD 20817. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: Michele L. Barnard, Ph.D., as amended. The grant applications and Scientific Review Officer, Review Branch, VerDate Sep<11>2014 16:49 Dec 30, 2015 Jkt 238001 PO 00000 Frm 00031 Fmt 4703 Sfmt 9990 E:\FR\FM\31DEN1.SGM 31DEN1


Document Created: 2015-12-31 02:15:03
Document Modified: 2015-12-31 02:15:03
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation80 FR 81835 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR